Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
Journal of Gynecologic Oncology
|
March 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer
Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura, et al.
Cancer Science
|
July 6, 2022
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826
Shin Nishio, Kan Yonemori, Tomoka Usami, et al.
International Journal of Clinical Oncology
|
December 6, 2024
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience
Mayu Yunokawa, Akiko Abe, Xiaofei Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2015
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour
Toyomi Satoh, Yoichi Aoki, Takahiro Kasamatsu, et al.
International Journal of Clinical Oncology
|
April 9, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study
Hidetaka Nomura, Akiko Abe, Atsushi Fusegi, et al.
Scientific Reports
|
January 8, 2022
Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
Motoko Kanno, Mayu Yunokawa, Makoto Nakabayashi, et al.
Oncogenesis
|
January 24, 2018
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
Ryo Tamura, Kosuke Yoshihara, Tetsuya Saito, et al.
Scientific Reports
|
January 19, 2023
Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
Hidetaka Nomura, Akiko Abe, Atsushi Fusegi, et al.
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Human Pathology
|
March 27, 2022
Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group
Hiroshi Yoshida, Akira Kikuchi, Hitoshi Tsuda, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
Journal of Gynecologic Oncology
|
March 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer
Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura, et al.
Cancer Science
|
July 6, 2022
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826
Shin Nishio, Kan Yonemori, Tomoka Usami, et al.
International Journal of Clinical Oncology
|
December 6, 2024
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience
Mayu Yunokawa, Akiko Abe, Xiaofei Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2015
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour
Toyomi Satoh, Yoichi Aoki, Takahiro Kasamatsu, et al.
International Journal of Clinical Oncology
|
April 9, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study
Hidetaka Nomura, Akiko Abe, Atsushi Fusegi, et al.
Scientific Reports
|
January 8, 2022
Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
Motoko Kanno, Mayu Yunokawa, Makoto Nakabayashi, et al.
Oncogenesis
|
January 24, 2018
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
Ryo Tamura, Kosuke Yoshihara, Tetsuya Saito, et al.
Scientific Reports
|
January 19, 2023
Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
Hidetaka Nomura, Akiko Abe, Atsushi Fusegi, et al.
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Human Pathology
|
March 27, 2022
Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group
Hiroshi Yoshida, Akira Kikuchi, Hitoshi Tsuda, et al.
Page
of 21